$RMTI

ROCKWELL MEDICAL, INC. (RMTI): Submission of Matters to a Vote of Security Holders

ROCKWELL MEDICAL, INC. (RMTI) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. rmti-20260612 0001041024 FALSE 0001041024 2026-06-12 2026-06-12 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):

Original reporting
Published Jun 15, 2026, 8:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 15, 2026, 8:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$RMTI
Neutral
medium confidence
Mentioned
$RMTI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$RMTINeutralLow
01

Why it matters

The key actionable corporate event disclosed is stockholder approval of an amendment to effect a reverse stock split; other items include director elections and ratification of the independent auditor.

02

Market read

Vote outcomes can influence trading via changes to share structure (reverse split) and governance expectations, but the filing lacks implementation specifics.

03

What to watch

Traders may need to wait for the actual effective date, ratio, and any related financing/listing compliance disclosures to gauge real impact.

Relevance 6/10Novelty 4/10Timing: after-hours/filing date (June 15, 2026) following June 12 annual meeting

Background

This is an SEC Form 8-K (Item 5.07) summarizing stockholder votes from Rockwell Medical’s June 12, 2026 annual meeting.

Company-level read

Ticker impact

$RMTINeutralMedium confidence
Context

Rockwell Medical reported 2026 annual meeting voting results, including a reverse stock split proposal and director elections.

Expected impact

Near-term volatility possible around implementation details; direction depends on whether the reverse split is expected to address listing/financing needs.

Evidence & confidence

The filing provides concrete outcomes for corporate governance items (reverse split approval, board elections, auditor ratification) but no implementation timeline or operational guidance.

Market effects

Limited sector read-through; reverse splits are company-specific and typically do not change industry fundamentals.

Minimal; impacts primarily the issuer’s US-listed equity liquidity and trading mechanics.

None indicated; filing is domestic corporate governance.

Counterpoint

Reverse splits can be purely administrative (e.g., share price management) and may not reflect deteriorating fundamentals.

Key entities

  • Rockwell Medical, Inc.

    Nasdaq Capital Market-listed company filing the 8-K and reporting annual meeting vote results.

  • EisnerAmper LLP

    Independent registered public accounting firm ratified for 2026 by stockholder vote.

Related articles

$RMTIMed

Vantive Announces Agreement to Divest Majority of Hemodialysis Assets and Associated Operations to Rockwell Medical

Vantive agreed to sell most of its hemodialysis assets to Rockwell Medical (RMTI) for $1.2B, focusing on home dialysis and critical care. The deal, expected to close in mid-2027, includes HD concentrates, monitors, and water treatment systems, but excludes Vantive's dialyzer portfolio. Both companies aim to enhance growth and innovation in kidney care.

$RMTIHigh

The Rockwell Medical deal leaves Vantive's blood-filtering devices out of the sale.

Vantive will sell its hemodialysis assets to Rockwell Medical (RMTI) for $1.5 billion, focusing on home dialysis and critical care. The deal, expected to close in mid-2027, includes HD monitors, water treatment systems, and related services. Vantive aims to enhance its kidney care platform, while Rockwell Medical plans to invest in the acquired business. Both companies emphasize continuity of care and innovation.

$RMTIMedAI 9/10

A factory campus in Italy spanning more than 1 million square feet is part of Rockwell Medical's planned deal.

Rockwell Medical (RMTI) is acquiring Vantive’s hemodialysis business, including products, a manufacturing campus in Italy, and a global customer base. The deal, expected to close mid-2027, aims to establish Rockwell as a leading hemodialysis provider with projected annual revenue of $400M-$450M. Rockwell withdrew its 2026 guidance due to acquisition-related expenses.

$RMTIMedAI 8/10

Rockwell Medical (RMTI) Q2 2026 Earnings Call Transcript

Rockwell Medical (RMTI) reported Q2 2026 net sales of $17.8 million, up 11% year over year, with gross profit $3.2 million and gross margin expanding to 18%. Net loss improved to $1.2 million, and operating cash flow turned positive at $2.1 million. FY 2026 guidance: revenue $70 million to $75 million, gross margin 18% to 22%, and adjusted EBITDA $1 million to $2 million. The company completed a 1-for-10 reverse split for Nasdaq bid-price compliance.